Masitinib
Masitinib is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in animals, specifically dogs. Since its introduction in November 2008 it has been distributed under the commercial name Masivet. It has been available in Europe since the second part of 2009. In the USA it is distributed under the name Kinavet and has been available for veterinaries since 2011.
| Catalog Number | T2609 |
| Alternative Name(s) | AB1010 |
| Research Area | Angiogenesis|||Tyrosine Kinase/Adaptors|||Apoptosis|||Cytoskeletal Signaling |
| Molecular Formula | C28H30N6OS |
| CAS# | 790299-79-5 |
| Purity | 99.91% |
| SMILES | CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1 |
| Size | 10 mg |
| Supplier Page | https://www.targetmol.com/compound/Masitinib |
| Additional Information | https://www.targetmol.com/datasheet/T2609 |